Neurocirugía Neurocirugía
Neurocirugia. 1993;04:115-9. - Vol. 04 Núm.02 DOI: 10.1016/S1130-1473(93)70860-X

Meningiomas de comportamiento agresivo

P. Díaza, A. Mailloa, F. Moralesa, J. Hemándeza, J.A. Gómez-Moretaa, I. Onzaina

a Servicio de Neurocirugía. Hospital Virgen de la Vega. Salamanca

Palabras clave

Meningiomas. Recidiva tumoral. Citometría de flujo. Receptores hormonales.

Resumen

El diagnóstico histopatológico es a veces un método impreciso para poder predecir la conducta biológica futura de los meningiomas intracraneales. Se describe el caso de una paciente que era portadora de un meningioma ventricular y cuya conducta revistió una gran agresividad a pesar de tener una apariencia histológicamente benigna. Esta conducta anormal podría ser detectable por medio de estudios de citometría de flujo y de receptores hormonales esteroideos.

El Texto completo solo esta disponible en PDF

Bibliografía

1.Adegbite AB, Khan MI, Paine KWE, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J. Neurosurg. 1983; 51-6.
2.Ahyai A, Zimmermann A, Spaar FW. Flow fluorescence cytometry of deoxyribonucleic acid in meningiomas: studies on surgically removed tumor specimens compared with their cells in primary tissue cultures. Surg. Neurol. 1983; 20:194-205.
Medline
3.Barbaro NM, Gutin PhH, Wilson ChB, Sheline GE, Boldrey EB, Wara WM. Radiation therapy in the treatment of partially resected meningiomas. Neurosurg. 1987; 20:525-8.
4.Benzel EC, Gelder BF. Correlation between sex hormone binding and peritumoral edema in intracranial meningiomas. Neurosurgery. 1988; 23:169-74.
Medline
5.Burns PE, Jha N, Bain GO. Association of breast cancer with meningioma: A report of five cases. Cancer. 1986; 58:1537-9.
Medline
6.Cahill DW, Bashlrelahi N, Saloman LW, Dalton T, Salcman M, Ducker TB. Estrogen and progesteron receptors in meningiomas. J. Neurosurg. 1984; 60:985-93.
Medline
7.Chan RC, Thompson GB. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. J. Neurosurg. 1984; 60:52-60.
Medline
8.Crone KR, Challa VRR, Kute TE, Moody DM, Kelly DL. Relationship between flow cytometric features and clinical behaviour of meningiomas. Neurosurgery. 1988; 23:720-4.
Medline
9.Crompton MR, Gautier-smith PC. The prediction of recurrence in meningiomas. J. Neurol. Neurosurg. Psychiat. 1970; 33:80-7.
Medline
10.Cushing H, Eisenhardt L. Meningiomas: Their classification, regional behaviour, life history and surgical end results. 2. New York: Hafner; 1966. 669–740
11.Donnell MS, Meyer GA, Donega WL. Estrogenreceptor protein in intracranial meningiomas. J. Neurosurg. 1977; 50:499-502.
Medline
12.Fromm P, Schäfer M, Vitzthum HG. Clinical course of intracranial meningiomas with respect to their histological stage. Acta Neurochir. 1975; 31:277. (abstract)
13.Frederiksen P, Reske-nielsen E, Bichel P. DNA content of meningiomas. Acta Neuropathol. 1979; 46:65-8.
Medline
14.Grunberg SM, Weiss MH, Spitz IM, Armadi J, Sadun A, Russell CA, Lucci L, Stevenson LL. Treatment of unresectable Meningiomas with the antiprogesterone agent miferpistone. J. Neurosurg. 1991; 74:861-6.
Medline
15.Henschen F. Tumoren des Zentralnervensystems und seiner Hüllen. Handbuch der speziellen pathologischen anatomie und histologie. 13. Springer-Verlag: Berlin/Göttingen/Heidelberg; 1955. 413-1040. (pp. 482–486) parto 3
16.Ironside JW, Battersby RDE, Lawry J, Loomes RS, Day CA, Timperley WR. DNA in meningioma tissues adn explant cell cultures. A flow cytometric study with clinopathological correlates. J. Neurosurg. 1987; 66:588-94.
Medline
17.Jensen VE. Horrnone dependency of breast cancer. Cancer. 1981; 47:2319-26.
Medline
18.Jellinger K, Slowik F. Histological subtypes and prognostic problems in meningiomas. J. Neurol. 1975; 208:279-98.
Medline
19.Jordan VC, Jacobson HI, Keenan EJ. Deterrnination of estrogen receptor in breast cancer using monoclonal antibody technology: Results of a multicenter study in the United States. Cancer Research. 1986; 46(Suppl):4237-40.
20.Kepes JJ. Meningiomas: Biology, pathology and differential diagnosis. 1. New York: Masson Publishing USA, Inc.; 1982. pp. 116–149
21.Knuckey NW, Stoll J, Epstein MH. Intracranial and spinal meningiomas in patients, with breast carcinoma: Case reports. Neurosurgery. 1989; 25:112-7.
Medline
22.Kumar PP, Patil AA, Leibrock LG, Chu W, Syh J, McCaul GP, Reeves MA. Brachytherapy: a viable altemative in the management of basal meningiomas. Neurosurg. 1991; 29:676-80.
23.Kornblum JA, Bay JW, Gupta MK. Steroid receptors in human brain and spinal cord tumors. Neurosurgery. 1988; 23:185-8.
Medline
24.Laerum OK, Farsund T. V. Clinical application of flow cytometry. A review. Cytometry. 1981; 2:1-13.
25.Makoto Shibuya, Takao Hoshino, Satoyuki Ito, Wacker Margaret R, Prados Michael D, Davis Richard L, Wilson Charles B. Meningiomas: Clinical implications of a high proliferative deterrnination by bromodeoxyuridine labeling. Neurosurg. 1992; 30:494-8.
26.May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE. The prediction of recurrence in meningiomas. A flow cytometric study of paraffinembedded archival material. J. Neurosurg. 1989; 71:347-51.
Medline
27.Mehta D, Khatub R, Patel S. Carcinoma of the breast and meningioma. Association and management. Cancer. 1983; 51:1937-40.
Medline
28.Mirimanoff RO, Dorosetz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma: Analysis of recurrence and progression following neurosurgical resection. J. Neurosurg. 1985; 62:18-24.
Medline
29.Osborne CK, Yochnowitz MG, Knrght WA, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980; 46:2884-8.
Medline
30.Petty AM, Kun LE, Meyer GA. Radiation therapy for incompletely resected meningiomas. Neurosurg. 1985; 62:502-7.
31.Porsson M, Pertuiset BF, Hauw JJ, Philippon J, Bufe A, Moguilewsky M, Philibert D. Steroid hormone receptors in human meningiomas, gliomas and brain metastasis. J. Neurooncol. 1983; 1:179-89.
Medline
32.Quest DO. Meningiomas: an update. Neurosurgery. 1978; 3:219-25.
Medline
33.Russell DS, Rubinstein LJ. Pathology of tumors of the nervous system. London: Edward Arnold; 1977. ed. 4, pp. 66–91
34.Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J. Neurol. Neurosurg. Psychiat. 1957; 20:22-39.
Medline
35.Skullernd K, Löken AC. The prognosis in meningiomas. Acta Neuropathol. 1974; 29:337-44.
Medline
36.Thomas HG, Dolman CL, Berry K. Malignant meningiomas: clinical and pathological features. J. Neurosurg. 1981; 55:929-34.
Medline
37.Turner OA, Cralg W, Kernohan JW. Malignant meningiomas: a clinical and pathological study. Surgery. 1942; 11:81-100.
38.Tytus JS, Lasersohn JT, Reifle S. The problem of malignancy in meningiomas. J. Neurosurg. 1967; 27:551-7.
Medline
39.Yamashita J, Handa H, Iwaki K, Abe M. Recurrence of intracranial meningiomas, with special reference to radiotherapy. Surg. Neurol. 1980; 14:33-40.
Medline